Uncategorised - Ataxia UK

Uncategorised

Co-designing audio support messages with and for people with ataxia: a telephone version of the “I’m not drunk” ID card

Upcoming project: Co-designing audio support messages with and for people with ataxia: a telephone version of the “I’m not drunk” ID card  Principal Investigators: Dr Maria Cairney and Prof Anja […]

Co-designing audio support messages with and for people with ataxia: a telephone version of the “I’m not drunk” ID card Read More »

Investigating The Molecular Mechanisms of SCA2 Using 3D Cerebellar Organoids and Multi-Omics Approaches: A Platform for Advancing Ataxia Research

Upcoming project: Investigating The Molecular Mechanisms of SCA2 Using 3D Cerebellar Organoids and Multi-Omics Approaches: A Platform for Advancing Ataxia Research Principal applicants: Prof Jorgen Erik Nielsen, Senior Researcher Patrick

Investigating The Molecular Mechanisms of SCA2 Using 3D Cerebellar Organoids and Multi-Omics Approaches: A Platform for Advancing Ataxia Research Read More »

Caring for people with progressive ataxia – lived experience of family carers and co-development of support mechanisms

Upcoming Project: Caring for people with progressive ataxia – lived experience of family carers and co-development of support mechanisms   Principal researchers: Prof Anja Lowit and Prof Christopher Graham, Strathclyde

Caring for people with progressive ataxia – lived experience of family carers and co-development of support mechanisms Read More »

Alterity Therapeutics announces positive results from its phase 2 trial of the drug ATH434 in MSA

On January 30th 2025, the pharmaceutical company Alterity Therapeutics announced positive data from their phase 2 placebo-controlled trial in early-stage MSA. MSA is a progressive neurological condition leading to impaired

Alterity Therapeutics announces positive results from its phase 2 trial of the drug ATH434 in MSA Read More »

Scroll to Top